Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methylation profiling in multiple myeloma.

C S Chim1, Y L Kwong, T K Fung

  • 1Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, PR China. jcschim@hkucc.hku.hk

Leukemia Research
|April 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003).

Blood cancer journal·2025
Same author

The functional role of surface molecules on extracellular vesicles in cancer, autoimmune diseases, and coagulopathy.

Journal of leukocyte biology·2020
Same author

Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Leukemia·2019
Same author

Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases.

Leukemia & lymphoma·2018
Same author

Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Leukemia·2017
Same author

[Recovery of hemoglobin level and blood pressure in workers unfit for duties at high altitude following relocation].

Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2017
Same journal

A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.

Leukemia research·2026
Same journal

FLAMSA versus FLAG-IDA as salvage therapy in adults with relapsed/refractory acute myeloid leukemia and acute lymphoblastic leukemia: A single-center real-world retrospective study.

Leukemia research·2026
Same journal

CD244 modulates bone marrow infiltrating CD8<sup>+</sup> T cells and serves as a prognostic and immunotherapeutic target in acute myeloid leukemia.

Leukemia research·2026
Same journal

Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.

Leukemia research·2026
Same journal

Real-world outcomes of plasmablastic lymphoma: Treatment approaches and survival outcomes in the PLASMABLAT-001 cohort.

Leukemia research·2026
Same journal

CRS and ICANS as class-level adverse event for CD20 ×CD3 bispecific T-cell engagers: A Bayesian analysis of a nationwide database.

Leukemia research·2026
See all related articles

Gene promoter hypermethylation is frequent in multiple myeloma (MM). Genes like p15, p16, ER, DAPK, and E-CAD are commonly methylated at diagnosis and progression, suggesting their role in MM development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Epigenetics

Background:

  • Epigenetic alterations, specifically DNA methylation, play a crucial role in cancer development.
  • Aberrant methylation patterns in tumor suppressor genes can lead to their silencing and contribute to oncogenesis.
  • Understanding methylation status in multiple myeloma (MM) is important for disease characterization and potential therapeutic targets.

Purpose of the Study:

  • To investigate the promoter methylation status of a panel of 10 genes in patients with multiple myeloma (MM) and plasmacytoma.
  • To determine if specific methylation patterns are associated with MM diagnosis and disease progression.
  • To identify potential epigenetic biomarkers for MM.

Main Methods:

  • Analysis of gene promoter methylation using methylation-specific polymerase chain reaction (MSP).

Related Experiment Videos

  • Primers were designed for both methylated (M-MSP) and unmethylated (U-MSP) DNA detection.
  • Samples analyzed included bone marrow from 13 MM patients and 1 plasmacytoma patient, along with 8 normal bone marrow controls.

    • Main Results:

    • None of the 10 genes showed methylation in normal bone marrow samples.
    • Hypermethylation of p15, p16, E-CAD, DAPK, and ER was frequently observed in MM patients at diagnosis and progression.
    • All diagnosed MM patients exhibited concurrent hypermethylation of at least three genes, with five patients showing methylation of four or more genes.

    Conclusions:

    • Genes p15, p16, ER, DAPK, and E-CAD are frequently methylated in multiple myeloma (MM) at both diagnosis and disease progression.
    • The genes RIZ1, p73, VHL, RARbeta, and MGMT were not found to be methylated in the studied MM samples.
    • Further large-scale studies are warranted to elucidate the role of these methylated genes in MM pathogenesis and progression.